Agrobacterium tumefaciens causes crown gall disease on a variety of plants. During the infection pro-
INTRODUCTION
The plant pathogen Agrobacterium tumefaciens has a tumourinducing (Ti) plasmid of which part, the transfer (T)-region, is transferred to plant cells during the infection process. As a result, the infected plant cells are triggered to divide, leading to the formation of crown gall tumours (reviewed in 1±8). The tumorous growth of the infected plant cells is caused by expression of the oncogenes located on the T-DNA. The vir region, also present on the Ti plasmid, encodes the Vir proteins, which mediate the processing of the T-region and the transfer of a single-stranded (ss) DNA copy of this region, the T-strand, into the recipient cells. One of the Vir proteins, the nicking enzyme VirD2, remains covalently attached to the 5¢ end of the T-strand. VirD2 pilots the T-strand to the plant cell nucleus by virtue of its nuclear localisation signal (NLS). Recently, we showed that, in addition to the nucleoprotein complex, A.tumefaciens translocates the Vir proteins VirE2 and VirF directly into plant cells (9) . Transport occurs via the VirB/VirD4 type IV secretion channel (7) . The ssDNAbinding protein VirE2 and the F-box protein VirF play a role in the process of plant transformation. The VirE2 protein protects the T-strand and is involved in its transport into the nucleus (10) . VirF can interact through its F-box with plant homologues of the yeast Skp1 protein (11) . Skp1 and F-box proteins are subunits of a class of E3 ubiquitin ligases, called SCF complexes. These SCF complexes target speci®c proteins through interaction with F-box proteins for ubiquitin-mediated proteolysis (12, 13) . However, the target of VirF remains unknown so far. The virF operon contains a single gene, but the adjacent virE operon embraces three genes, namely virE1, virE2 and virE3. The VirE1 protein plays an important role in the transport of VirE2 by acting as a chaperone of this protein and thus preventing at the same time premature binding to the T-strand and VirE2 aggregate formation (14, 15) . The function of the VirE3 protein has not been established, but virFvirE3 double mutants are more strongly attenuated in virulence than virF mutants (B.Schrammeijer, P.Zuiderwijk and P.J.J.Hooykaas, unpublished results).
Agrobacterium tumefaciens can also transfer T-DNA to Saccharomyces cerevisiae (16) and ®lamentous fungi (17) . The VirE2 and VirF proteins are not necessary for this process. The question was therefore raised whether A.tumefaciens nevertheless still translocates the Vir proteins VirE2 and VirF into yeast in a process that resembles translocation into plant cells. To study this, we made use of the site-speci®c recombination system Cre/lox of bacteriophage P1 (reviewed in 18) , analogous to what was used to show direct Vir protein translocation from Agrobacterium into plants (9) . Delivery of a bacterially expressed functional Cre recombinase fused to the VirE2 or VirF proteins into yeast cells was detected by selection for loss of a lox¯anked (floxed) URA3 marker gene due to Cre recombination activity (Fig. 1) . Our results indicate that A.tumefaciens indeed translocates VirE2 and VirF proteins directly into S.cerevisiae and that this translocation occurs via the VirB/VirD4 transport system as in plants. The yeast system thus offers a suitable and fast model system for the study of trans-kingdom protein translocation from Agrobacterium. We applied the system to show that the presence of the IncW plasmid pSa Osa protein, which inhibits tumour formation by Agrobacterium (19±21) blocks VirE2 and VirF protein transfer. Moreover we found evidence for the translocation of a third effector protein, the VirE3 protein, into yeast.
MATERIALS AND METHODS

Construction of a S.cerevisiae strain containing a floxed URA3 gene
The URA3 gene was cloned as a HindIII fragment from pJJ244 (22) into the ®lled-in EcoRI site of pIC-2lox (23) resulting in pSDM3011. The resulting floxed URA3 gene was subcloned as a HindIII fragment into pUC4a10 (24) , which contains part of the PDA1 locus (pSDM3012). Finally, the PDA1-lox-URA3-lox-PDA1 cassette was cloned into binary vector pBin19 (25) resulting in pSDM3013. Agrobacterium tumefaciens strain LBA1126 (26) was electroporated (27) with pSDM3013 and used in a co-cultivation experiment with S.cerevisiae strain RSY12 (MATa leu2-3, 112 his3-11, 15 ura3D::HIS3) (28). Transformants, prototrophic for uracil, were selected on minimal yeast (MY) medium (29) containing 200 mM cefotaxim (Duchefa, B.V.), leucine (30 mg/l) and histidine (20 mg/l) but lacking uracil. Transformants were further characterised with polymerase chain reaction (PCR) and Southern blot analysis. Strain LBY2, in which the loxURA3lox gene had integrated at the PDA1 locus on chromosome V by homologous recombination (gene replacement), was selected and used in all co-cultivation experiments.
Construction of cre control and cre fusion plasmids
Cre control. The cre recombinase gene was cloned as an SphI/ EcoRI fragment from pUC19Cre (30) into pUC21 (31) (pSDM3120). The ATG start codon was removed by replacing the BglII/NruI fragment in pSDM3120 by a BglII/NruIdigested PCR fragment, ampli®ed with primers cre 1 (5¢-ggcagatctgTCCAATTTACTG-3¢) and cre 2 (5¢-GATAA-TCGCGAACATCTTCAGG-3¢) (restriction sites underlined) using pSDM3120 as template (pSDM3121). A 2.2-kb SalI fragment from pRAL3248 (32) , containing virE promoter, virE1 and virE2(D30 3¢ bp), was cloned into the XhoI site of pSDM3121 (pSDM3122). Digestion with BglII and BstYI (partial) followed by ligation of the vector (pSDM3126) resulted in transcriptional control of cre from the virE promoter at the start codon position of virE2 (pvirE-virE1-cre). This cassette was cloned into the SmaI/XbaI sites of the broad host range, non-mobilisable plasmid pRL662 (9) (pSDM3147 or cre control).
virE2::cre fusion. VirE2 was fused translationally to the 5¢ end of the cre gene in several steps. The pvirE-virE1-virE2(D30 3¢ bp)::cre cassette from pSDM3122 was cloned into the SmaI/ XbaI sites of pRL662 (pSDM3148). The 3¢ end of the virE2 gene was restored as follows. The BglII/NruI fragment of pSDM3122 (cre1-205 DATG) was cloned into pIC19R (33) and named pSDM3151. A 34-bp SalI/BglII linker (5¢-TCGACCGCGTAGCCAAAGCGTCAACAGCTTTCGA-3¢) representing the 3¢ 30 bp of virE2 but lacking the stop codon was cloned into pSDM3151 (pSDM3152). The SalI fragment of pRAL3248 [pvirE-virE1-virE2(D30 3¢ bp)] was cloned into pSDM3152 resulting in a translational fusion of full length virE2 with cre (pSDM3157). The NruI fragment in pSDM3148 was ®nally replaced by the NruI fragment of pSDM3157 resulting in plasmid pSDM3166 carrying the pvirE-virE1-virE2::cre cassette.
cre::virE2 fusion. To remove the STOP codon of the cre gene primers cre 6 (5¢-acgcgtcgactATCGCCATCTTC-CAGCAGGCGC-3¢) and cre 7 (5¢-cCATCGATTGATTA-CGGCGCTAAGG-3¢) were used in a PCR ampli®cation with pSDM3126 as template DNA. After digestion with ClaI (underlined) and SalI (underlined) the fragment was used to replace the corresponding fragment in pSDM3126 (pSDM3127 or creDSTOP). An XhoI/SmaI fragment from pRAL3248 (32) was inserted into XhoI/EcoRV-digested pBluescriptIISK ± (34) followed by insertion of an XhoI/StuI linker (5¢-tcgaGATCTTTCTGGCAATGAGAAATCAGG-3¢) resulting in pBluevirE2DATG. VirE2DATG was then fused in frame to the 3¢ end of cre as an XhoI/NotI fragment into the SalI/NotI sites of pSDM3127 (pSDM3128). Finally, a StuI/ XbaI fragment was cloned into the SmaI/XbaI sites of pRL662 resulting in pSDM3129 harbouring the pvirE-virE1-cre::virE2 cassette.
NLS::virF::cre fusion. A SacI/EcoRV 5¢ virF¯ank from pTi15955, containing the ribosome binding site, was subcloned from pRAL7088 (35) into pBluescriptIISK ± (pSDM3183). The NLS from simian virus 40 (SV40), containing an ATG start codon, was synthesised (Eurogentec, Belgium) with EcoRV and SalI sites, and cloned into pSDM3183 (pSDM3184). VirFDATGD495±609 was cloned downstream the SV40 NLS in pSDM3184 (XhoI) as a SalI/XhoI fragment from pSDM3193 (11) and named pSDM3185. To remove the STOP codon in virF a 175-bp fragment of the 3¢ coding region was ampli®ed with primers PF170 (5¢-ATCCCTAACTTGGTCTTCAAC-3¢) and PF583 (5¢-cttagatcTAGACCGCGCGTTGATCGAGG-3¢) containing a BglII site at the 5¢ end (underlined) using pRAL7088 (35) as template DNA. After subcloning the PCR fragment into the pGEM T-vector (Promega) VirFDSTOP was cloned into XhoI/BglII-digested pSDM3121-L, which resulted after insertion of a StuI/BglII linker (5¢-CCTCGAGCCCGGGATA-3¢) into pSDM3121 (pSDM3186). The 3¢ virF::cre fusion was cloned into the XhoI site of pSDM3185 (pSDM3187 or NLS::virF::cre) and subsequently into SacI/PstI digested pUC28 (36) . The ®nal pvirF-NLS::virF::cre cassette was cloned into EcoRI digested pRL662 (pSDM3153).
NLS::cre::virF fusion. The 5¢ virF¯ank±SV40NLS cassette from pSDM3184 was subcloned into pIC19H (SacI/SalI) (33), followed by a HindIII/SalI cloning into pIC19R and ®nally cloned as an XhoI/SalI fragment into the XhoI site of pSDM3121 (pSDM3188). Exchange of the ClaI/SalI 3¢ cre fragment from pSDM3188 by the ClaI/SalI fragment from pSDM3127 resulted in a pvirF-NLS::creDSTOP cassette (pSDM3179). VirFDATG was cloned as a SalI/EagI fragment from pSDM3193 (11) into the SalI/NotI sites of pSDM3179 (pSDM3189). The pvirF-NLS::cre::virF cassette was ®nally inserted into HindIII/XbaI digested pRL662 (pSDM3154).
NLS::cre::virFD1±126 fusion. Deletion of the 126 5¢ base pairs of the virF gene (D1±126) results in an N-terminal truncated VirFD42N protein lacking the F-box. The SaII/EagI fragment from pSDM3194 (11) was cloned into the SalI/NotI sites of pSDM3179, resulting in pSDM3190 with a pvirF-NLS::cre::virFD1±126 cassette. This cassette was transferred into pRL662 as a HindIII/XbaI fragment (pSDM3155).
NLS::cre::virE3. The virE3 gene was cloned as an EcoRV/ SacI fragment from pRAL3248 (32) into pIC20R (33) resulting in pSDM3006. First, the 3¢ coding region was subcloned in SalI/PstI digested pBluescriptIIKS (pSDM3503). The ATG start codon was removed by PCR ampli®cation with primers virE3-1 (5¢-ACGCgtcgacagatctGCGTGAGCACTA-CGAAGAAAAG) and virE3-2B (5¢-AGCCTATTTCGC-CACGAAACCC) with pSDM3006 as template DNA. SalIdigested PCR fragment (underlined) was cloned into pSDM3503 (pSDM3504). The ®nal virE3DATG gene was ligated into SalI/XbaI digested pSDM3197, which resulted from cloning a HindIII/XbaI fragment from pSDM3179 in pRL662, and removal of the second SalI site in proximity to the virF promoter sequence. The ®nal plasmid harbouring the pvirF-NLS::cre::virE3 cassette was named pSDM3507.
The in frame fusions of all plasmids as well as the accurate SV40NLS and 3¢ virF fragment sequences were con®rmed by sequence analysis.
Construction of the pOsa plasmid. The osa gene under control of the tac promoter was cloned from pUFR047::ptacosa into pRL662 (pOsa or pSDM3180).
Agrobacterium tumefaciens strains
The stably maintained non-mobilisable plasmids pSDM3166 (virE2::cre), pSDM3129 (cre::virE2), pSDM3153 (NLS::virF::cre), pSDM3154 (NLS::cre::virF), pSDM3155 (NLS::cre::virFD1±126) and pSDM3507 (cre::virE3) were electroporated in Agrobacterium strain LBA1100, harbouring a disarmed octopine pTi plasmid named pAL1100 (37), according to den Dulk-Ras and Hooykaas (27) . Furthermore, pSDM3129 and pSDM3155 were introduced in LBA2561, a LBA1100 derivative deleted for the virF gene (35) , as well as in a series of LBA1100 derived vir mutants (37) having a Tn3hoho1 transposon insertion in virA (LBA1142), virB4 (LBA1143), virB7 (LBA1144), virC2 (LBA1146), virD1 (LBA1150), virD2 (LBA1147), virD4 (LBA1148), virE2 (LBA1149) or virG (LBA1145). pNLS::cre::virFD1±126 was also introduced into LBA2565 (LBA1100DvirE3). The strains LBA1147 and LBA1150 contained plasmid pSDM3191 (or pD3,D4) to complement for polar mutation of downstream located virD3 and virD4. As control pSDM3191 was introduced in LBA1100. pD3,D4 was made by cloning the virD3 and virD4 genes behind the virD promoter as a 4.4-kb BamHI fragment from pMP3 (38) into pSDM3015. pSDM3015 is a derivative of pBin19 (25) in which the T-region was replaced by the pIC19R/H polylinker sequence (33) .
Agrobacterium strain LBA1100 was electroporated with the integrative cre control plasmid pSDM3126 or cre::virE2 fusion plasmid pSDM3128, resulting in LBA1100::cre and LBA1100::cre::virE2, respectively. Selection for integration of the introduced plasmid via homologous recombination at the virE1 locus of pAL1100 was done on LC medium (10 g/l bacto-tryptone, 5 g/l bacto-yeast extract and 8 g/l NaCl, pH 7) containing carbenicillin (100 mg/ml) and integration was con®rmed by Southern blot analysis. The same was performed for strain LBA2561 with plasmid pSDM3190, resulting in LBA2561::NLS::cre::virFD1±126 expressing the Cre::VirFD42N protein. Here, integration of the plasmid occurred at the 5¢ virF¯ank of pAL1100DvirF. pSDM3180 (pOsa) was introduced in LBA1100::cre::virE2 and LBA2561::NLS::cre::virFD1±126.
Protein transport experiments
Agrobacterium strains expressing the cre or cre-fusion gene were grown overnight at 29°C in 5 ml minimal medium (MM) (39) supplemented with spectinomycin (250 mg/ml) and, in case a pRL662-based plasmid was present, also with gentamycin (40 mg/ml). Cells were harvested and diluted at an A600 of 0.25 in 5 ml induction medium [IM: MM salts and 40 mM 2-(N-morpholino) ethanesulfonic acid, pH 5.3, 10 mM glucose, 0.5% (w/v) glycerol and 200 mM acetosyringone (AS)]. The cells were then grown for 5 h at 28°C.
Saccharomyces cerevisiae strain LBY2 was grown overnight at 30°C in 10 ml yeast-peptone-dextrose (YPD) medium (40) . Cells were 1:10 diluted in fresh 100 ml YPD medium and grown for 5 h at 30°C. The cells were subsequently washed with and resuspended in 500 ml IM. Aliquots of 100 ml of the Agrobacterium and Saccharomyces cultures were mixed 1:1, the mixture was placed on 0.45 mm cellulose nitrate ®lters on IM containing 5 mM glucose and the amino acids leucine and uracil at a concentration of 30 mg/l. To prevent loss of pRL662 gentamycin was added to the medium. After 6 days of co-cultivation at 22°C, the mixture was resuspended in 2 ml NaCl solution (9 g/l) and 100 ml aliquots (undiluted and a 10 ±2 dilution) were plated out on solid MY medium supplemented with leucine, uracil, 200 mM cefotaxim and 0.1%¯uoro-orotic acid (FOA). The number of colonies that had lost the URA3 gene as indicated by growth on FOA were calculated after 4 days growth at 30°C. The output number of Agrobacterium cells (n.b. of viable cells after co-cultivation) was determined on solid LC medium supplemented with spectinomycin or gentamycin by plating a 10 ±5 and a 10 ±6 dilution of the cocultivation mix. The output number of Saccharomyces cells was determined on solid MY medium with cefotaxim and the amino acids leucine and uracil by plating a 10 ±4 and a 10 ±5 dilution of the co-cultivation mix. The ef®ciency of excision of the URA3 gene is indicated as the number of yeast colonies on FOA divided by the number of surviving yeast colonies (output yeast).
RESULTS
Translocation of the Cre::VirE2 and NLS::Cre::VirF fusion proteins from A.tumefaciens into S.cerevisiae Agrobacterium tumefaciens can introduce T-DNA not only into plants but also into yeast and other fungi. In plants transfer of the Vir proteins VirE2 and VirF, which function in the plant cell in the process of tumour formation, accompanies T-DNA transfer. These transferred proteins are not essential for T-DNA transfer to yeast (16) . We studied whether translocation of these proteins from A.tumefaciens into yeast occurs nevertheless as this might offer a fast and simple system for the study of this process of trans-kingdom protein translocation. To this end, we employed a similar strategy (see Fig. 1 ) as used to demonstrate protein translocation from Agrobacterium into plants (9) . This strategy is based on the Cre/lox system from bacteriophage P1. Translational fusions of the cre gene with the 3¢ or 5¢ end of the virE2 and virF gene were placed under control of the virE and virF promoter, respectively. The SV40 NLS was added to the Cre-VirF fusion proteins to ensure nuclear targeting. The virE2 fusion genes were coordinately expressed with the virE1 gene. The cre gene transcriptionally fused to the virE1 gene and under control of the virE promoter was used as a control. To analyse protein transfer in the absence of T-DNA, the donor strains expressing the Cre fusion proteins contained a disarmed octopine Ti plasmid. The recipient yeast strain LBY2 carried a floxed URA3 gene integrated at the PDA1 locus on chromosome V. Delivery of a functional Cre enzyme into this yeast was monitored by Cre-mediated loss of the floxed URA3 gene due to site-speci®c recombination on the lox sites. Positive selection for loss of the URA3 gene was performed on medium containing FOA. Expression and recombination activity of the fusion proteins in A.tumefaciens was reported earlier (9) . Results of a representative co-cultivation experiment are shown in Table 1 . Co-cultivation with donor strains expressing the Cre recombinase alone, the VirE2::Cre or the NLS::VirF::Cre protein resulted in only a few Ura ± colonies, which was similar to the number of Ura ± colonies obtained after co-cultivation with an Agrobacterium strain lacking Cre altogether [ Table 1 ; LBA1100 (none)]. However, when Cre was fused to the N-terminus of VirE2 (Cre::VirE2) or VirF (NLS::Cre::VirF) a large increase in the frequency of Ura ± colonies per output recipient yeast (see Materials and Methods and legend to Table 1 for calculation of the frequency) was obtained (Table 1) . These results show that delivery of Cre from A.tumefaciens into S.cerevisiae only occurs ef®ciently when Cre is fused to the N-terminus of VirE2 or VirF as is the case with transfer into plants.
Recently, we showed that VirF contains an F-box domain at its N-terminus by which it can bind to F-box interacting plant proteins (11) . In co-cultivation experiments with plant cells, removal of the F-box from the NLS::Cre::VirF fusion protein (NLS::Cre::VirFD42N) led to a 5-fold increase in the frequency of a Cre-mediated excision event, possibly due to an increased stability of the protein or the inability of the protein to bind with F-box interacting proteins in the cytoplasm (9) . In transport experiments with yeast as a recipient, the F-box deleted version did not result in an increase in the number of colonies that had lost the URA3 gene (Table 1) The results shown in the previous paragraph indicate that Agrobacterium translocates the VirE2 and VirF proteins into yeast. To analyse whether translocation from Agrobacterium into yeast has the same requirements as translocation into plants, the fusion proteins were expressed from a nonmobilisable broad host range plasmid in a set of vir mutants (donors) harbouring an octopine Ti plasmid lacking the T-region. Results of a representative co-cultivation experiment are given in Table 2A and B, respectively. Co-cultivation of yeast with donor strains carrying a mutation in virA or virG did not result in the generation of Ura ± colonies at a frequency
higher than the background level [LBA1100 (wild type vir) expressing only Cre]. This was expected since the VirA/VirG two component regulatory system is responsible for transcriptional activation of all the vir genes. Similar low numbers of Ura ± colonies were detected after co-cultivation of yeast with donor strains having a (polar) mutation in virB4, (Table 2B ) and VirE1 (data not shown). These results show that the VirB and VirD4 proteins that are required for VirE2 and VirF protein translocation into plants are equally important for Vir protein translocation into yeast. The yeast system thus offers a good model system to study protein translocation from Agrobacterium. We used it in the next two paragraphs to study transport of a putative third effector protein and to study the effect of tumourigenesisinhibitor Osa on protein translocation.
Identi®cation of a third effector protein, VirE3
The translocated VirE2 and VirF proteins do not share an obvious transport domain. However, deletion analysis has shown that the transport signal is located in the C-terminal part of these proteins. A common Arg-Pro-Arg motif can be identi®ed in this region and may form part of the transport signal (9) . An Arg-Pro-Arg sequence is also present in the C-terminal region of the virulence protein VirE3. Although the function of this protein is still an enigma, it is worth noting that this protein has been conserved in all the different types of Ti and Ri plasmids. As the Arg-Pro-Arg motif indicated that VirE3 might be a transported effector protein of the Agrobacterium virulence system, we fused the N-terminus of VirE3 to NLS::Cre and assayed in the yeast system whether translocation of the fusion protein took place. The results of a representative experiment are summarised in No transport of NLS::Cre::VirE3 was detected from a virD4 mutant, which is defective in type IV secretion (data not shown).
Osa inhibits Vir protein translocation from Agrobacterium into yeast
VirE2 or virF mutants (T-DNA donors) can be`extracellularly' complemented for tumour formation on plants by coinfection with a helper strain lacking the T-region but containing the vir region including virE2 or virF, respectively (32,41±43). It has been found that the presence of the osa gene from IncW plasmid pSa in A.tumefaciens abolishes tumourigenicity on plants (44) . Later, Lee et al. (45) showed that extracellular' complementation for tumour formation of a virE2 mutant on plants was inhibited by the presence of the osa gene in the helper strain but not by its presence in the T-DNA donor strain. These results indirectly indicate that Osa inhibits VirE2 transport rather than T-DNA transfer from Agrobacterium to plants. We have studied this possible inhibition of VirE2 and VirF transport by Osa in a direct assay. To this end, pOsa (pSDM3180) (containing the osa gene behind the tac promoter) was used in our protein transfer system to study the inhibitory effect of Osa on the translocation of Cre::VirE2 and NLS::Cre::VirFD42N from Agrobacterium into yeast. Results of a representative cocultivation experiment are given in Table 4 . Translocation of Cre::VirE2 or NLS::Cre::VirFD42N from Agrobacterium into LBY2 resulted in a large increase of the frequency of Ura ± colonies per output recipient compared with the control strain that expresses only Cre. In the presence of pOsa a complete inhibition of Cre::VirE2 and NLS::Cre:VirFD42N translocation from Agrobacterium into yeast was observed, providing direct evidence for inhibition of Vir protein transport from Agrobacterium by Osa.
DISCUSSION
Here, we report a novel and fast method to detect A.tumefaciens Vir protein transport. We show that Agrobacterium not only transfers T-DNA to the yeast S.cerevisiae during co-cultivation (16) but also translocates the Vir proteins VirE2, VirE3 and VirF directly into yeast cells. Virulence studies on plants have shown that an Agrobacterium strain mutated in the virE2 gene is avirulent on most plant species while a strain mutated in the virF gene is attenuated in virulence on certain host plants (43, 46, 47) . The attenuated virulence of virF mutants is aggravated by a mutation in the virE3 gene (B.Schrammeijer, P.Zuiderwijk and P.J.J.Hooykaas, unpublished results). Both VirE2 and VirF play a role in the plant cell during tumourigenesis: plants expressing either VirE2 or VirF become hosts for virE2 and virF mutants, respectively (48, 49) . VirE2 attaches to the Tstrand by cooperative binding thereby protecting the T-strand from degradation in the plant cell (50) . Such coating is important for ef®cient entrance of the T-strand into the plant nucleus (8, 10) . VirF is an F-box protein that interacts with homologues of the yeast Skp1 protein in plants (11) . F-box proteins and Skp1 form a part of SCF complexes, which are responsible for the ubiquitin-mediated proteolysis of speci®c plant proteins. VirF as part of such an SCF complex in plants, may be involved in the targeted proteolysis of speci®c host proteins during tumourigenesis by A.tumefaciens (11) .
Recently, it was shown in our group that T-DNA transfer from virE2 or virF mutants to S.cerevisiae was not or only slightly affected compared with the wild type strain (16 VirB secretion system in the presence of coupling factor VirD4 as was shown for plants (9) . This indicates that both Vir proteins are actively translocated through the same pore/pilus like structure through which the T-strand is transferred into the yeast cell (16) . In addition, we found now that VirE3 is also transported through this VirB/D4 channel.
The VirB/VirD4 transport system of A.tumefaciens is the prototype of the TFSS (reviewed in 7). Other members of this family of TFSSs are the conjugative DNA transport systems encoded by the (broad host range) plasmids IncW, IncN and IncP. In several animal pathogens, like Helicobacter pylori, Bordetella pertussis, Legionella pneumophila, Rickettsia prowazekii and Brucella suis, similar secretion systems are present that may not be involved in DNA transfer, but in protein export. Evidence for protein secretion has been found for the Bordetella and Helicobacter systems (reviewed in 51). It is entirely possible that the TFSSs involved in DNA translocation have evolved from a protein transport system. In this scenario the relaxase bound to the 5¢ end of the DNA acts as a pilot protein that is recognised by the TFSS.
Translocation of VirE2 is independent of VirF and translocation of VirF is independent of VirE2 and VirE3. The VirE3 protein is encoded by a gene, which was identi®ed downstream of the virE2 gene on Ti plasmids (52±54). Mutations in virE3 aggravate the attenuated virulence of virF mutants. We now show that the translocation of VirF into yeast is not affected by the absence of VirE3 from the bacterium, and that VirE3 itself is a translocated effector protein. Further study is necessary to reveal the role of VirE3 during tumourigenesis on plants.
For delivery of Cre into yeast cells mediated by VirE2 or VirF transport signals, the Cre protein must be fused to the Nterminus of either Vir protein, as was the case for delivery of Cre into plant cells (9) . Interestingly, the 37 C-terminally located amino acids of VirF were suf®cient to introduce Cre into yeast (data not shown), as in plants (9) . These results show that the same transport signals located in the C-terminus of VirE2 and VirF are important to mediate translocation into plant and yeast cells. In agreement with a C-terminal transport signal, VirE3 was able to transport Cre into yeast as an N-terminal fusion. The common Arg-Pro-Arg motif that is present in the C-termini of VirE2, VirE3 and VirF may form part of the transport domain. Currently, we are analysing the C-terminal signal sequences in more detail.
To ensure nuclear targeting of the Cre::VirF fusion constructs the SV40 NLS sequence was fused translationally to the N-terminus. Guralnick et al. (55) suggested that the NLS sequences present in VirE2 are unable to mediate entrance into the nucleus of Drosophila embryos or Xenopus oocytes and that they are rather plant speci®c. Recently, Rhee et al. (56) showed in a genetic assay the inability of the VirE2 NLS to function in nuclear import in yeast cells. Here, we show that Removal of the N-terminus from VirF, including the F-box (42 amino acids), resulted in a 5-fold higher ef®ciency of Cre-mediated deletion in Arabidopsis (9). The same high ef®ciency was obtained in Arabidopsis for the NLS::Cre::VirF(LP®AA) fusion protein (data not shown). Deletion or mutation of the F-box from VirF may stabilise the VirF fusion protein in plants by preventing VirF from binding to F-box interacting proteins (Skp1 orthologs) in the plant cytoplasm (11) , ultimately leading to an increase in the numbers of NLS::Cre::VirFD42N or NLS::Cre:: VirF(LP®AA) molecules that reach the plant cell nucleus (9) . However, the absence or mutation of this F-box from VirF did not lead to the detection of enhanced Cre activity in yeast. This difference might be the result of distinct binding af®nities in yeast and plants between the full length VirF protein and the Skp1 orthologs, making the full length VirF protein more stable in yeast. Another explanation might be that a different factor, such as the number of yeast cells competent for transformation, is limited for translocation to yeast, thus concealing the effect of deletion of the F-box.
Previously, it was suggested that oncogenic suppression by Osa involves inhibition of VirE2 transport rather than T-DNA transfer from A.tumefaciens to plants (45) . We have con®rmed this in our direct protein transport assay. Moreover, we have shown that inhibition of protein transfer is not restricted to VirE2, but involved at least VirF also. The molecular mechanism by which Osa inhibits protein transport is unknown. In a previous article it was proposed that Osa may do this by interacting with VirE1, which is needed for VirE2 transport from the bacterium (45) . However, as transport of VirF, which does not need VirE1 (data not shown), is inhibited by Osa we also think it is unlikely that Osa's inhibitory effects are a result of its interaction with VirE1. Recently, we have done experiments to see whether Osa may compete with VirE2 and VirF export by being a favoured translocation protein itself. However, preliminary results indicate that Osa is not transported by the VirB/VirD4 secretion channel (data not shown). Therefore, at the moment we favour the idea that Osa, being a membrane protein, either inhibits the function of one of the proteins of the VirB/VirD4 type IV secretion channel or binds to the transported Vir proteins (VirE2, VirF) and thereby prevents these from being exported. Further research has to clarify the mechanism by which Osa inhibits Vir protein transport from Agrobacterium into the host cell.
Our results indicate that the A.tumefaciens system, which has so far been used as a tool to introduce genes of interest into plants, yeast and other fungi, also offers potential for delivering proteins of interest fused to VirE2, VirE3 or VirF or their transport domain(s) into plants, yeast and fungi.
Most of the techniques to mutate yeast genes are based on homologous recombination events during mitosis (58) . Nutritional markers are commonly used as selection markers in yeast (59) . However, the availability of different nutritional markers for selection is limited. An alternative is the kan R marker, which has been shown to be a good marker in yeast (60) . Recently, mutagenesis methods were developed in which sequences homologous to the target site in the yeast genome (61) contain a selection marker¯anked by speci®c target sites (e.g. lox-kanMX-lox) for recombinases (e.g. Cre recombinase). The selection marker is now removed by introducing a plasmid expressing the Cre protein in the yeast cell. Furthermore, this plasmid has to be removed again from the yeast strain. The method of protein transport (of a functional recombinase) described in this paper avoids the need to introduce and subsequently remove a Cre expressing plasmid. Therefore, with this Cre-Vir/lox system we provide a fast method to mediate site-speci®c recombination events in yeast. Besides, the trans-kingdom protein transfer to yeast offers a fast and reliable alternative for translocation studies of virulence effectors from bacteria carrying a TFSS.
